Major beta blocker mortality trials in chronic heart failure: a critical review

Heart. 1999 Dec;82 Suppl 4(Suppl 4):IV14-22. doi: 10.1136/hrt.82.2008.iv14.

Author

Affiliation

¹ CRI in Heart Failure, Wolfson Building, University of Glasgow, Glasgow G12 8QQ. j.mcmurray@bio.gla.ac.uk

No abstract available

Publication types

Meta-Analysis

MeSH terms

Adrenergic beta-Antagonists / adverse effects
Adrenergic beta-Antagonists / therapeutic use*
Aged
Aged, 80 and over
Bisoprolol / therapeutic use
Carbazoles / therapeutic use
Carvedilol
Female
Heart Failure / drug therapy*
Heart Failure / etiology
Heart Failure / mortality*
Humans
Male
Metoprolol / therapeutic use
Morbidity
Multicenter Studies as Topic
Propanolamines / therapeutic use
Prospective Studies
Randomized Controlled Trials as Topic
Ventricular Dysfunction, Left / complications
Ventricular Dysfunction, Left / drug therapy
Ventricular Dysfunction, Left / mortality

Substances

Adrenergic beta-Antagonists
Carbazoles
Propanolamines
Carvedilol
Metoprolol
Bisoprolol